Alnylam Pharmaceuticals, Inc., an American company at the forefront of innovation, today received the 2024 Tell Award from Ambassador Niculin Jaeger, Consul General of Switzerland, and Artur ...

Purdue Pharma headquarters; Victor J. Blue/Bloomberg via Getty Images(NEW YORK) -- The company and once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribut ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

We recently compiled a list of the These 10 Companies Led Gains on Wednesday. In this article, we are going to take a look at ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA approved.

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...

We recently published a list of Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks. In this article, we are going to ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

Before beginning the discussion of where this company is going, let's set expectations appropriately. Moderna won't be ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.